Cymbalta vs. Lexapro: Key Differences and What You Need to Know
Author:
Blossom Editorial
Mar 17, 2026
If you’re exploring treatment options for depression or anxiety, your provider may mention Cymbalta (duloxetine) or Lexapro (escitalopram). These are two of the most commonly prescribed antidepressants that work in different ways.
Both medications are well-studied and can be effective for treating certain mental health conditions. But they differ in how they work, what conditions they treat, and what side effects to expect.
Understanding these differences can help you have more informed conversations with your provider about treatment options.
Key Takeaways
Both Cymbalta and Lexapro are used to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). Research suggests they have similar effectiveness for depression, although some studies find Lexapro may be slightly better tolerated overall.
Cymbalta affects both serotonin and norepinephrine, while Lexapro mainly targets serotonin. Because of this difference, Cymbalta may sometimes be used for people with underlying chronic pain conditions like diabetic neuropathy or fibromyalgia.
The choice of treatment depends on your symptoms, medical history, and how your body responds to treatment. A healthcare provider can help guide this decision based on your individual needs.
What Is Cymbalta (Duloxetine)?
Cymbalta is a serotonin and norepinephrine reuptake inhibitor (SNRI) - a class of antidepressants that increase levels of both serotonin and norepinephrine in the brain.
It is FDA-approved to treat:
Major depressive disorder (MDD)
Generalized anxiety disorder (GAD)
Diabetic peripheral neuropathic pain
Fibromyalgia
Chronic musculoskeletal pain.
The standard dosage for depression in adults typically starts at 40mg (20mg twice daily) and can be increased to 60mg (once daily or 30mg twice daily). The typical starting dose for anxiety is 60mg once daily. Cymbalta’s ability to act on two neurotransmitters makes it a broad range treatment option for several conditions as compared to Lexapro. This also helps treat chronic pain as pain signals in the spinal cord use both serotonin and norepinephrine.
What Is Lexapro (Escitalopram)?
Lexapro is a selective serotonin reuptake inhibitor (SSRI) - a class of antidepressant that increases serotonin levels in the brain.
It is FDA-approved for MDD and GAD. The typical starting dose for adults is 10 mg once daily, with a maximum of 20 mg. Lexapro is considered a very selective SSRIs, meaning it has fewer effects on other brain receptors. This may lead to fewer side effects for some people. Lexapro is often prescribed as a first-line treatment for depression and anxiety because research suggests it is effective and generally well-tolerated. It is also one of the most commonly prescribed antidepressants worldwide.
How Do Cymbalta and Lexapro Compare?
Effectiveness for Depression
Several research reviews have compared Cymbalta (duloxetine) and Lexapro (escitalopram) for treating major depressive disorder.
A meta-analysis published in Neuropsychiatric Disease and Treatment reviewed multiple randomized controlled trials. Some results suggested that escitalopram worked slightly better, while others found no meaningful difference between the two medications.
A larger systematic review published in BMC Psychiatry looked at 30 studies and found that escitalopram was more effective than duloxetine overall and was also better tolerated by patients.
A Cochrane review of duloxetine found that duloxetine did not show meaningful effectiveness over other antidepressants for depression. The review also noted that more patients discontinued duloxetine compared to escitalopram.
However, it’s important to note that differences between antidepressants are usually small at the population level. What often matters most is how you respond to a specific medication.
Effectiveness for Anxiety
Both medications are FDA-approved for GAD and have strong evidence supporting their effectiveness.
Some clinicians use Lexapro as a first-line option for anxiety because it is often well-tolerated. Cymbalta may be considered when anxiety co-occurs with chronic pain or when patients have not responded well to SSRIs alone.
Because Cymbalta affects both serotonin and norepinephrine, it may also help with some of the physical symptoms of anxiety. These include fatigue, muscle tension, and concentration difficulties.
Side Effect Comparison
Both medications can cause similar side effects. Common ones include nausea, headache, drowsiness, insomnia, dry mouth, and sexual side effects.
However, there are some important differences:
Cymbalta tends to cause more: Sweating, constipation, dizziness, and small increases in blood pressure. Some studies have also noted that more people stopped taking duloxetine compared to escitalopram.
Lexapro tends to cause more: Slightly more weight gain over time compared to duloxetine in some studies. In an 8-month comparison study, people taking escitalopram gained an average of 1.83 kg compared to 0.61 kg for people taking duloxetine.
Sexual side effects: Both medications can affect sexual function. Clinical trial data suggest duloxetine may cause slightly fewer sexual side effects than escitalopram in the short term.
Discontinuation: Both medications can cause withdrawal symptoms if they are stopped abruptly. Duloxetine is particularly known for discontinuation symptoms. For this reason, healthcare providers usually recommend gradually tapering the dose rather than stopping abruptly.
Pain Management
One of the biggest differences between the two medications is pain treatment. Cymbalta is FDA-approved to treat several chronic pain conditions, such as diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain.
Lexapro does not have FDA-approval for any pain-related conditions..
If someone is living with both depression or anxiety and chronic pain, Cymbalta may be a practical option. This is because it can treat both conditions with a single medication, potentially reducing the total number of medications needed.
Switching Between Cymbalta and Lexapro
If a medication isn’t working well or is causing difficult side effects, a healthcare provider may recommend switching to the other.
Switching antidepressants typically involves gradually lowering the current medication while carefully starting a new one. In some cases, a short washout period may also be used. This helps reduce the risk of withdrawal symptoms, serotonin syndrome, or symptom relapse.
Antidepressants should never be stopped or switched without medical supervision. Always work with your prescriber to develop a safe transition plan.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. The information provided should not replace consultation with a qualified healthcare provider. Individual responses to medications can vary significantly, and what applies to one person may not be the same for another.
Always consult with your doctor or pharmacist before making any decisions about medication changes, discontinuation, or interactions with other substances. If you’re experiencing concerning symptoms or side effects, please seek professional help from a healthcare provider.
In case of a medical emergency, contact your local emergency services immediately or call 911. For mental health emergencies, contact the National Suicide Prevention Lifeline at 988.
Sources
Drugs.com. (July 21, 2025). Cymbalta. https://www.drugs.com/dosage/cymbalta.html
Drugs.com. (November 17, 2025). Lexapro. https://www.drugs.com/pro/lexapro.html
Maneeton, B., Maneeton, N., Likhitsathian, S., Woottiluk, P., Wiriyacosol, P., Boonyanaruthee, V., & Srisurapanont, M. (2018). Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review. Neuropsychiatric disease and treatment, 14, 1953–1961. https://doi.org/10.2147/NDT.S1524102.
Yin, J., Song, X., Wang, C., Lin, X., & Miao, M. (2023). Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis. BMC psychiatry, 23(1), 876. https://doi.org/10.1186/s12888-023-05382-83.
Cipriani, A., Koesters, M., Furukawa, T. A., Nosè, M., Purgato, M., Omori, I. M., Trespidi, C., & Barbui, C. (2012). Duloxetine versus other anti-depressive agents for depression. The Cochrane database of systematic reviews, 10(10), CD006533. https://doi.org/10.1002/14651858.CD006533.pub2
Cipriani, A., Santilli, C., Furukawa, T. A., Signoretti, A., Nakagawa, A., McGuire, H., Churchill, R., & Barbui, C. (2009). Escitalopram versus other antidepressive agents for depression. The Cochrane database of systematic reviews, (2), CD006532. https://doi.org/10.1002/14651858.CD006532.pub2
Pigott, T. A., Prakash, A., Arnold, L. M., Aaronson, S. T., Mallinckrodt, C. H., & Wohlreich, M. M. (2007). Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. Current medical research and opinion, 23(6), 1303–1318. https://doi.org/10.1185/030079907X1881077. Clayton, A., Kornstein, S., Prakash, A., Mallinckrodt, C., & Wohlreich, M. (2007). Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. The journal of sexual medicine, 4(4 Pt 1), 917–929. https://doi.org/10.1111/j.1743-6109.2007.00520.x
National Institute of Mental Health. (December 2023). Mental Health Medications.
